1. A multi‐centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T‐prolymphocytic leukaemia or mantle cell lymphoma. (23rd June 2017) Authors: Pratt, Guy; Yap, Christina; Oldreive, Ceri; Slade, Daniel; Bishop, Rebecca; Griffiths, Mike; Dyer, Martin J. S.; Fegan, Chris; Oscier, David; Pettitt, Andrew; Matutes, Estella; Devereux, Stephen; Allsup, David; Bloor, Adrian; Hillmen, Peter; Follows, George; Rule, Simon; Moss, Paul; Stankovic, Ta... Journal: British journal of haematology Issue: Volume 182:Number 3(2018) Page Start: 429 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial. Issue 10232 (18th April 2020) Authors: Sharman, Jeff P; Egyed, Miklos; Jurczak, Wojciech; Skarbnik, Alan; Pagel, John M; Flinn, Ian W; Kamdar, Manali; Munir, Talha; Walewska, Renata; Corbett, Gillian; Fogliatto, Laura Maria; Herishanu, Yair; Banerji, Versha; Coutre, Steven; Follows, George; Walker, Patricia; Karlsson, Karin; Ghia, Pao... Journal: Lancet Issue: Volume 395:Issue 10232(2020) Page Start: 1278 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: Patient outcomes and impact of bendamustine dosing. Issue 5 (20th March 2023) Authors: Arulogun, Suzanne O.; Brian, Duncan; Goradia, Harshita; Cooney, Aaron; Menne, Tobias; Koo, RayMun; O'Neill, Aideen T.; Vos, Josephine M. I.; Pratt, Guy; Turner, Deborah; Marshall, Kirsty; Manos, Kate; Anderson, Claire; Gavriatopoulou, Maria; Kyriakou, Charalampia; Kersten, Marie J.; Minnema, Moni... Journal: American journal of hematology Issue: Volume 98:Issue 5(2023) Page Start: 750 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post‐BCR inhibitor setting: a UK wide analysis. (15th February 2019) Authors: Eyre, Toby A.; Kirkwood, Amy A.; Gohill, Sat; Follows, George; Walewska, Renata; Walter, Harriet; Cross, Matthew; Forconi, Francesco; Shah, Nimish; Chasty, Richard; Hart, Alistair; Broom, Angus; Marr, Helen; Patten, Piers E. M.; Dann, Andy; Arumainathan, Arvind; Munir, Tal; Shankara, Paneesha; Bl... Journal: British journal of haematology Issue: Volume 185:Number 4(2019) Page Start: 656 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Epstein-Barr Virus-associated Diffuse Large B-cell Lymphoma Identified in a Breast Implant Capsule: A New Breast Implant-Associated Lymphoma?. Issue 4 (April 2021) Authors: Malata, Charles M.; Madada-Nyakauru, Rudo N.; Follows, George; Wright, Penny Journal: Annals of plastic surgery Issue: Volume 86:Issue 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Eradication of minimal residual disease improves overall and progression‐free survival in patients with chronic lymphocytic leukaemia, evidence from NCRN CLL207: a phase II trial assessing alemtuzumab consolidation. (29th December 2016) Authors: Varghese, Abraham M.; Howard, Dena R.; Pocock, Christopher; Rawstron, Andy C.; Follows, George; McCarthy, Helen; Dearden, Claire; Fegan, Christopher; Milligan, Donald; Smith, Alexandra F.; Gregory, Walter; Hillmen, Peter Journal: British journal of haematology Issue: Volume 176:Number 4(2017) Page Start: 573 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Guideline for the treatment of chronic lymphocytic leukaemia. (21st March 2022) Authors: Walewska, Renata; Parry‐Jones, Nilima; Eyre, Toby A.; Follows, George; Martinez‐Calle, Nicolas; McCarthy, Helen; Parry, Helen; Patten, Piers E. M.; Riches, John C.; Hillmen, Peter; Schuh, Anna H. Journal: British journal of haematology Issue: Volume 197:Number 5(2022) Page Start: 544 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Guideline for the treatment of chronic lymphocytic leukaemia: A British Society for Haematology Guideline. (15th July 2018) Authors: Schuh, Anna H.; Parry‐Jones, Nilima; Appleby, Niamh; Bloor, Adrian; Dearden, Claire E.; Fegan, Christopher; Follows, George; Fox, Christopher P.; Iyengar, Sunil; Kennedy, Ben; McCarthy, Helen; Parry, Helen M.; Patten, Piers; Pettitt, Andrew R.; Ringshausen, Ingo; Walewska, Renata; Hillmen, Peter Journal: British journal of haematology Issue: Volume 182:Number 3(2018) Page Start: 344 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Ibrutinib for mantle cell lymphoma at first relapse: a United Kingdom real‐world analysis of outcomes in 211 patients. (23rd February 2021) Authors: McCulloch, Rory; Lewis, David; Crosbie, Nicola; Eyre, Toby A.; Bolam, Simon; Arasaretnam, Anita; Creasey, Thomas; Goradia, Harshita; McMillan, Annabel; Dawi, Safia; Harrison, Samuel; Miles, Oliver; Robinson, Andrew; Dutton, David; Wilson, Matthew R.; McKay, Pam; Follows, George; Phillips, Neil; P... Journal: British journal of haematology Issue: Volume 193:Number 2(2021) Page Start: 290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Ibrutinib is a safe and effective therapy for systemic mantle cell lymphoma with central nervous system involvement – a multi‐centre case series from the United Kingdom. (16th May 2016) Authors: Tucker, David L.; Naylor, Georgina; Kruger, Anton; Hamilton, Malcolm S.; Follows, George; Rule, Simon A. Journal: British journal of haematology Issue: Volume 178:Number 2(2017) Page Start: 327 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗